The Cooper Companies, Inc. (COO) Net Profit Margin: 5.57%
Is The Cooper Companies, Inc.’s net profit margin high or low?
The Cooper Companies, Inc.'s net profit margin of 5.57% is 78% below its 5-year average of 24.94%, near the low end of its 5-year range (5.57%–100.76%).
As of Sunday, June 14, 2026. 42.07% below its 12-month average of 9.62%.
COO Net Profit Margin Chart
COO Average Net Profit Margin Chart
COO Current vs Average Net Profit Margin Chart
COO Net Profit Margin Metrics
NET PROFIT MARGIN
5.57%
NET PROFIT MARGIN AVG TTM
9.62%
NET PROFIT MARGIN AVG 3Y
9.77%
NET PROFIT MARGIN AVG 5Y
24.94%
NET PROFIT MARGIN AVG 10Y
19.59%
NET PROFIT MARGIN AVG 15Y
18.12%
NET PROFIT MARGIN AVG 20Y
15.39%
CURRENT VS TTM AVG
-42.07%
CURRENT VS 3Y AVG
-42.99%
CURRENT VS 5Y AVG
-77.67%
CURRENT VS 10Y AVG
-71.56%
CURRENT VS 15Y AVG
-69.26%
CURRENT VS 20Y AVG
-63.82%
COO Competitors' Net Profit Margin
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| The Cooper Companies, Inc. (COO) | $13.24B | 5.57% | 9.62% | 9.77% | 24.94% |
| Solventum Corporation (SOLV) | $13.66B | 17.33% | 12.25% | 14.36% | 15.15% |
| Align Technology, Inc. (ALGN) | $12.52B | 10.50% | 10.36% | 10.48% | 22.21% |
| Baxter International Inc. (BAX) | $10.77B | -9.70% | -7.30% | -3.29% | 1.14% |
| Walgreens Boots Alliance, Inc. (WBA) | $10.37B | -4.07% | -4.03% | -0.72% | 0.14% |
| Hologic, Inc. (HOLX) | $16.97B | 13.18% | 16.70% | 17.87% | 22.37% |
| Charles River Laboratories International, Inc. (CRL) | $9.03B | -4.59% | -1.67% | 5.09% | 7.31% |
| Tempus AI, Inc. (TEM) | $8.35B | -22.20% | -60.53% | -62.93% | -77.31% |
| Bio-Rad Laboratories, Inc. (BIO) | $7.73B | 6.52% | -21.22% | -48.94% | 16.61% |
| Moderna, Inc. (MRNA) | $19.80B | -143.55% | -128.24% | -70.25% | -50.87% |
Margin Comparison
Operating Margin
11.8%
Net Profit Margin
5.6%
The Cooper Companies, Inc. Net Profit Margin Formula & Definition
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
The Cooper Companies, Inc. Net Profit Margin FAQ
- What is the net profit margin for The Cooper Companies, Inc. (COO)?
- The net profit margin for COO stock is 5.57%.
- Is The Cooper Companies, Inc.'s net profit margin high or low?
- The Cooper Companies, Inc.'s net profit margin of 5.57% is 78% below its 5-year average of 24.94%, near the low end of its 5-year range (5.57%–100.76%).
- What is the TTM average net profit margin for The Cooper Companies, Inc. (COO)?
- The TTM average net profit margin for COO stock is 9.62%.
- What is the 3Y average net profit margin for The Cooper Companies, Inc. (COO)?
- The 3Y average net profit margin for COO stock is 9.77%.
- What is the 5Y average net profit margin for The Cooper Companies, Inc. (COO)?
- The 5Y average net profit margin for COO stock is 24.94%.
- What is the 10Y average net profit margin for The Cooper Companies, Inc. (COO)?
- The 10Y average net profit margin for COO stock is 19.59%.
- What is the 15Y average net profit margin for The Cooper Companies, Inc. (COO)?
- The 15Y average net profit margin for COO stock is 18.12%.
- What is the 20Y average net profit margin for The Cooper Companies, Inc. (COO)?
- The 20Y average net profit margin for COO stock is 15.39%.
The Cooper Companies, Inc. Net Profit Margin History
| DATE | NET PROFIT MARGIN |
|---|---|
| 2025-10-31 | 9.16% |
| 2024-10-31 | 10.07% |
| 2023-10-31 | 8.19% |
| 2022-10-31 | 11.66% |
| 2021-10-31 | 100.76% |
| 2020-10-31 | 9.81% |
| 2019-10-31 | 17.59% |
| 2018-10-31 | 5.52% |
| 2017-10-31 | 17.43% |
| 2016-10-31 | 13.93% |
| 2015-10-31 | 11.33% |
| 2014-10-31 | 15.71% |
| 2013-10-31 | 18.65% |
| 2012-10-31 | 17.18% |
| 2011-10-31 | 13.18% |
| 2010-10-31 | 9.74% |
| 2009-10-31 | 9.31% |
| 2008-10-31 | 6.16% |
| 2007-10-31 | -1.18% |
| 2006-10-31 | 7.71% |
| 2005-10-31 | 11.37% |
| 2004-10-31 | 18.94% |
| 2003-10-31 | 16.70% |
| 2002-10-31 | 15.50% |
| 2001-10-31 | 15.83% |
| 2000-10-31 | 14.68% |
| 1999-10-31 | 15.18% |
| 1998-10-31 | 27.04% |
| 1997-10-31 | 22.19% |
| 1996-10-31 | 15.22% |
Related Metrics
About The Cooper Companies, Inc.
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Albert G. White